Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Hepatitis A Vaccine Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Hepatitis A Vaccine Market Status and Forecast (2016-2027)
      • 1.3.2 Global Hepatitis A Vaccine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Hepatitis A Vaccine Supply by Company

    • 2.1 Global Hepatitis A Vaccine Sales Volume by Company
    • 2.2 Global Hepatitis A Vaccine Sales Value by Company
    • 2.3 Global Hepatitis A Vaccine Price by Company
    • 2.4 Hepatitis A Vaccine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Hepatitis A Vaccine Market Status by Category

    • 3.1 Hepatitis A Vaccine Category Introduction
      • 3.1.1 Inactivated Vaccine
      • 3.1.2 Live Attenuated Vaccine
    • 3.2 Global Hepatitis A Vaccine Market by Category
      • 3.2.1 Global Hepatitis A Vaccine Sales Volume by Category (2016-2021)
      • 3.2.2 Global Hepatitis A Vaccine Sales Value by Category (2016-2021)
      • 3.2.3 Global Hepatitis A Vaccine Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Hepatitis A Vaccine Market Status by End User/Segment

    • 4.1 Hepatitis A Vaccine Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinic
      • 4.1.3 Other
    • 4.2 Global Hepatitis A Vaccine Market by End User/Segment
      • 4.2.1 Global Hepatitis A Vaccine Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Hepatitis A Vaccine Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Hepatitis A Vaccine Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Hepatitis A Vaccine Market Status by Region

    • 5.1 Global Hepatitis A Vaccine Market by Region
      • 5.1.1 Global Hepatitis A Vaccine Sales Volume by Region
      • 5.1.2 Global Hepatitis A Vaccine Sales Value by Region
    • 5.2 North America Hepatitis A Vaccine Market Status
    • 5.3 Europe Hepatitis A Vaccine Market Status
    • 5.4 Asia Pacific Hepatitis A Vaccine Market Status
    • 5.5 Central & South America Hepatitis A Vaccine Market Status
    • 5.6 Middle East & Africa Hepatitis A Vaccine Market Status

    6 North America Hepatitis A Vaccine Market Status

    • 6.1 North America Hepatitis A Vaccine Market by Country
      • 6.1.1 North America Hepatitis A Vaccine Sales Volume by Country (2016-2021)
      • 6.1.2 North America Hepatitis A Vaccine Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Hepatitis A Vaccine Market Status

    • 7.1 Europe Hepatitis A Vaccine Market by Country
      • 7.1.1 Europe Hepatitis A Vaccine Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Hepatitis A Vaccine Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Hepatitis A Vaccine Market Status

    • 8.1 Asia Pacific Hepatitis A Vaccine Market by Country
      • 8.1.1 Asia Pacific Hepatitis A Vaccine Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Hepatitis A Vaccine Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Hepatitis A Vaccine Market Status

    • 9.1 Central & South America Hepatitis A Vaccine Market by Country
      • 9.1.1 Central & South America Hepatitis A Vaccine Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Hepatitis A Vaccine Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Hepatitis A Vaccine Market Status

    • 10.1 Middle East & Africa Hepatitis A Vaccine Market by Country
      • 10.1.1 Middle East & Africa Hepatitis A Vaccine Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Hepatitis A Vaccine Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Hepatitis A Vaccine Distributors
    • 11.3 Hepatitis A Vaccine Buyers

    12 Global Hepatitis A Vaccine Market Forecast by Category and by End User/Segment

    • 12.1 Global Hepatitis A Vaccine Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Hepatitis A Vaccine Forecast by Category
      • 12.2.1 Global Hepatitis A Vaccine Sales Volume Forecast by Category
      • 12.2.2 Global Hepatitis A Vaccine Sales Value Forecast by Category
      • 12.2.3 Global Hepatitis A Vaccine Price Forecast by Category
    • 12.3 Global Hepatitis A Vaccine Forecast by End User/Segment
      • 12.3.1 Global Hepatitis A Vaccine Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Hepatitis A Vaccine Sales Value Forecast by End User/Segment
      • 12.3.3 Global Hepatitis A Vaccine Price Forecast by End User/Segment

    13 Global Hepatitis A Vaccine Market Forecast by Region/Country

    • 13.1 Global Hepatitis A Vaccine Market Forecast by Region (2022-2027)
      • 13.1.1 Global Hepatitis A Vaccine Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Hepatitis A Vaccine Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 GSK
      • 14.1.1 Company Information
      • 14.1.2 Hepatitis A Vaccine Product Introduction
      • 14.1.3 GSK Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Merck
      • 14.2.1 Company Information
      • 14.2.2 Hepatitis A Vaccine Product Introduction
      • 14.2.3 Merck Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 KM Biologics
      • 14.3.1 Company Information
      • 14.3.2 Hepatitis A Vaccine Product Introduction
      • 14.3.3 KM Biologics Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Sinovac
      • 14.4.1 Company Information
      • 14.4.2 Hepatitis A Vaccine Product Introduction
      • 14.4.3 Sinovac Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Sanofi
      • 14.5.1 Company Information
      • 14.5.2 Hepatitis A Vaccine Product Introduction
      • 14.5.3 Sanofi Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 IMBCA
      • 14.6.1 Company Information
      • 14.6.2 Hepatitis A Vaccine Product Introduction
      • 14.6.3 IMBCA Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Changchun Institute of Biological
      • 14.7.1 Company Information
      • 14.7.2 Hepatitis A Vaccine Product Introduction
      • 14.7.3 Changchun Institute of Biological Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Zhejiang Pukang
      • 14.8.1 Company Information
      • 14.8.2 Hepatitis A Vaccine Product Introduction
      • 14.8.3 Zhejiang Pukang Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Convac
      • 14.9.1 Company Information
      • 14.9.2 Hepatitis A Vaccine Product Introduction
      • 14.9.3 Convac Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 ChangSheng
      • 14.10.1 Company Information
      • 14.10.2 Hepatitis A Vaccine Product Introduction
      • 14.10.3 ChangSheng Hepatitis A Vaccine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Hepatitis A Vaccine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Hepatitis A Vaccine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Inactivated Vaccine
    Live Attenuated Vaccine

    Segmented by End User/Segment
    Hospital
    Clinic
    Other

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    GSK
    Merck
    KM Biologics
    Sinovac
    Sanofi
    IMBCA
    Changchun Institute of Biological
    Zhejiang Pukang
    Convac
    ChangSheng

    Buy now